Gabriel Schneider is Vice President at Acorn Bioventures, a New York-based venture capital firm investing in small-cap biotech and medtech companies. He is part of the firm's leadership team.
At firms with a similar stage, sector and check size.



One email when Gabriel's firm raises a fund, adds a partner or shows new activity.

Raising a pre-seed or seed round? We write $1M to $5M first checks and help founders with distribution. A partner reads every deck.
Send your deckGabriel Schneider is Vice President at Acorn Bioventures, a New York-based venture capital firm investing in small-cap biotech and medtech companies. He is part of the firm's leadership team.
Gabriel Schneider invests through Acorn Bioventures, which writes checks of $100K to $10M at seed, series a, series b.
A warm intro from a founder Acorn Bioventures backed works best.
Last updated 2026-10-15. Is this you? Ask for a correction.